Vaccine Advancement, Efficacy and Safety
A section of Vaccines (ISSN 2076-393X).
Editorial Board
Special Issues
Following special issues within this section are currently open for submissions:
- Clinical Strategies to Improve Efficacy, Effectiveness, and Safety of Vaccination in Humans (Deadline: 31 July 2025)
- Promoting Research, Development and Access to Vaccines to Address Global Inequities (Deadline: 31 October 2025)
- New Approaches to Vaccine Development and Delivery (Deadline: 31 October 2025)
- Vaccine Efficacy and Safety in Transplant Recipients (Deadline: 31 October 2025)
- Vaccine Efficacy and Safety in Patients with Immune-Mediated Intestinal Diseases (Deadline: 30 November 2025)
- Evaluation of Vaccine Efficacy, Safety and Immunogenicity Against Influenza, RSV and COVID-19 (Deadline: 31 December 2025)
- Effectiveness and Safety of Vaccines in Special Populations (Deadline: 31 January 2026)
- Safety and Side Effects in SARS-CoV-2 Vaccine (Deadline: 28 February 2026)
- Advancements in Vaccine Research: Epidemiology, Immunogenicity, Effectiveness and Safety (Deadline: 20 March 2026)
- Safety and Immunogenicty of Vaccination (Deadline: 31 May 2026)
Topical Collection
Following topical collection within this section is currently open for submissions:
